Applied Therapeutics, Inc. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/733b4fba-58a3-4096-a271-5bacaca91c1d/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-105.6M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-053840 |
| FY 2023 | $-119.8M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002541 |
| FY 2022 | $-82.5M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-004398 |
| FY 2021 | $-105.6M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-003206 |
| FY 2020 | $-94.0M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-003180 |
| FY 2019 | $-45.5M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002630 |
| FY 2018 | $-16.5M | 2018-01-01 – 2018-12-31 | evidence 0001558370-20-002630 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).